Part 4/5:

With the subsequent approval of the drug TRIAA by the FDA, a wave of optimism swept through the cystic fibrosis community. For countless patients staring down what felt like a death sentence in their twenties or thirties, the medication essentially commuted those grim expectations.

At the age of 27, Gunner found himself confronting a reality he had never considered possible: a future beyond just survival. Realizing that he could think about tomorrow, next week, or even next month filled him with hope.